Page last updated: 2024-11-07

methylprednisolone acetate and Retinal Neovascularization

methylprednisolone acetate has been researched along with Retinal Neovascularization in 1 studies

Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.

Retinal Neovascularization: Formation of new blood vessels originating from the retinal veins and extending along the inner (vitreal) surface of the retina.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ober, MD1
Del Priore, LV1
Tsai, J1
Lopez, R1
Lobes, LA1
Puklin, JE1
Young, T1

Other Studies

1 other study available for methylprednisolone acetate and Retinal Neovascularization

ArticleYear
Diagnostic and therapeutic challenges.
    Retina (Philadelphia, Pa.), 2006, Volume: 26, Issue:4

    Topics: Adolescent; Anemia; Anti-Inflammatory Agents; Cardiomyopathies; Epoetin Alfa; Erythropoietin; Fluore

2006